References: Asymptomatic peripheral artery disease or intermittent claudication
Chuter V, Quigley F, Tosenovsky P, Ritter J, Charles J, Cheney J, et al. Peripheral artery disease: Australian guidelines on diagnosis and management of peripheral artery disease. In: Lazzarini P, Raspovic A, Prentice J, Commons R, Fitridge R, Charles J, et al. 2021 Australian evidence-based guidelines for diabetes-related foot disease. Brisbane, Australia: Diabetes Feet Australia, Australian Diabetes Society; 2021. https://www.diabetesfeetaustralia.org/new-guidelines/
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017;377(14):1319-30. https://www.ncbi.nlm.nih.gov/pubmed/28844192
European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32(22):2851-906. https://www.ncbi.nlm.nih.gov/pubmed/21873417
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135(12):e726-e79. https://www.ncbi.nlm.nih.gov/pubmed/27840333
